You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
CATHEPSIN L INHIBITORS AS PAN CORONAVIRUS THERAPEUTICS
SBC: PHELIX THERAPEUTICS LLC Topic: RDESCRIPTION provided by applicant Coronaviruses CoV are RNA viruses that cause gastrointestinal respiratory and neurological symptoms in several mammalian species The outbreak of the severe acute respiratory syndrome CoV SARS CoV in humans was fatal in of infected patients infecting people and killing The recent incidents involving the highly pathogenic Middle East ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Wave Detection, Prediction, and Reaction System (WDPRS)
SBC: DANIEL H WAGNER ASSOCIATES INC Topic: N10AT036In this Phase II SBIR project, Daniel H. Wagner Associates (DHWA), with NASAs Jet Propulsion Laboratory (JPL), MARK Resources, Inc. (MRI), and Spatial Integrated Systems (SIS) as our subcontractors, will develop a prototype lightweight, low-cost Wave Detection, Prediction, and Reaction System (WDPRS), and then test and evaluate its performance at-sea. The proposed WDPRS is designed to reduce the h ...
SBIR Phase II 2013 Department of DefenseNavy -
Tolerability of SRX246 in Huntington's Disease Patients
SBC: Azevan Pharmaceuticals Inc Topic: 950DESCRIPTION provided by applicant Huntingtonandapos s Disease HD is an inherited disease that results from expansion of a trinucleotide CAG cytosine adenine guanine repeat that encodes a polyglutamine tract in the huntingtin protein Psychiatric symptoms including irritability and aggression are common in HD patients These are among the most distressing aspects of the disease They hav ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Preserving beta-lactam utility vs pathogens producing any class of beta-lactamase
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTION provided by applicant Multi drug resistance in Enterobacteriaceae is regarded as a healthcare crisis This crisis has been further amplified by the recent emergence of the NDM andquot super bug geneandquot a zinc based metallo lactamase Amber Class B in Enterobacteriaceae Members of this family of resistance enzymes are found on promiscuous plasmids with other MDR resistance mechanisms ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Phase II SBIR: Responding to NDM-1- Advancement of a new MBL inhibitor to IND
SBC: VENATORX PHARMACEUTICALS INC Topic: NIAIDDESCRIPTION provided by applicant Multi drug resistance in Enterobacteriaceae is regarded as a healthcare crisis While carbapenems are among the most prescribed antibiotics for infections caused by these organisms carbapenem resistance conferred by zinc based metallo carbapenemases Amber Class B is a growing global health concern that threatens to erode the efficacy of these antibiotics both in th ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension
SBC: Pulmokine, Inc. Topic: NHLBIDESCRIPTION provided by applicant Pulmokine is developing a novel inhaled PDGF receptor PDGFR kinase inhibitor PK as a treatment for Pulmonary Arterial Hypertension PAH The purpose of this Phase IIB Small Market Bridge Award is to progress PK through a phase A clinical trial for safety PAH is an orphan disease with high morbidity and mortality despite currently available treat ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Clinical and Non Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology
SBC: PHARMACOPHOTONICS, INC. Topic: 400DESCRIPTION provided by applicant Pharmaco Photonics DBA FAST Biomedical proposes a PHASE IIB project to determine the safety and functionality of repeat administration of the FAST PV and mGFR Technology in both non clinical and clinical studies The long term goal of this SBIR project is to test FASTandapos s fluorescent based test in humans and commercializes this product for rapid detecti ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Conformational Stabilization of the HIV-1 Env Trimer
SBC: AVATAR MEDICAL, LLC Topic: NIAIDDESCRIPTION provided by applicant Avatar is developing HIV vaccine immunogens based on dityrosine DT crosslinking of soluble native Env gp trimers Several of the most potent broadly neutralizing Abs andquot bnAbsandquot preferentially bind native Env trimers and a trimeric immunogen thus would both present a wide range of key neutralizing epitopes and simultaneously focus immune responses away fro ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
A Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
SBC: THERMAL GRADIENT, INC. Topic: NIAIDDESCRIPTION provided by applicant Rapid Portable HIV Detection and Monitoring System The long term objectives of this project are Develop a prototype of a rapid portable instrument for detecting and measuring the amount of Human Immunodeficiency Viruses HIVandapos s in samples of patient blood particularly in low resource settings Carry out a pilot study to establish the effectivene ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Magnetic Flow Sorter for Pancreatic Islet Isolation
SBC: TECHSHOT, INC. Topic: NIDDKDESCRIPTION (provided by applicant): Techshot, Inc. has successfully completed SBIR Phase I and Phase II research demonstrating that magnetically labeled porcine islets of Langerhans can be isolated from contaminating exocrine tissue by flow sorting usinga quadrupole magnetic separator ( Quadrasep ) designed for that purpose. Magnetically sorted islets are superior in morphology and physiology to ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health